Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

Authors: Wiam A Alashek, Christopher W McIntyre, Maarten W Taal

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Patients receiving maintenance haemodialysis (HD) are at higher risk for acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general population. Strict infection control measures are essential to prevent nosocomial transmission. We aimed to investigate the incidence and prevalence of HBV and HCV infection in the HD population of Libya as well as risk factors for infection.

Methods

All adult patients receiving maintenance HD (n=2382) in Libyan dialysis centres (n=39) were studied between May 2009 and October 2010. Testing for Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies was performed at initiation of dialysis and every 3–6 months thereafter. Patients who were sero-negative for HBV and HCV (n=1160) were followed up for 1 year to detect sero-conversions.

Results

Participant median age was 49 years and 58% were male. 831 patients (34.9%) were sero-positive for HBV and/or HCV (anti-HCV positive 31.1%; HBsAg positive 2.6%; both positive 1.2%). Of the sero-positive patients 4.7% were known to be infected before the initiation of HD. The prevalence of HBV±HCV infection varied widely between HD centres from 0% to 75.9%. Sero-positive patients were younger, had longer time on dialysis and more previous blood transfusions. Prospective follow-up revealed an incidence of sero-conversion of 7.7% during 1 year (7.1% HCV; 0.6% HBV). Wide variation in rates of newly acquired infections was observed between dialysis centres. All new HBV cases were referred from centres already treating HBV infected patients. New HCV infections were reported in most centres but the rate of HCV sero-conversion varied widely from 1.5% to 31%. Duration of dialysis, history of previous renal transplant and history of receiving HD in another centre in Libya were significantly associated with sero-conversion.

Conclusion

Patients on maintenance HD in Libya have a high incidence and prevalence of HCV infection and lower rates of HBV infection. The factors associated with HBV and HCV infection are highly suggestive of nosocomial transmission within HD units. Urgent action is required to improve infection control measures in HD centres and to reduce dependence on blood transfusions for the treatment of anaemia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002, 36 (1): 3-10.CrossRefPubMed Fabrizi F, Poordad FF, Martin P: Hepatitis C infection and the patient with end-stage renal disease. Hepatology. 2002, 36 (1): 3-10.CrossRefPubMed
2.
go back to reference Fabrizi F, Lunghi G, Martin P: Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol. 2002, 15 (5): 463-468.PubMed Fabrizi F, Lunghi G, Martin P: Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol. 2002, 15 (5): 463-468.PubMed
3.
go back to reference Taal MW, van Zyl-Smit R: Hepatitis C virus infection in chronic haemodialysis patients–relationship to blood transfusions and dialyser re-use. S Afr Med J. 2000, 90 (6): 621-625.PubMed Taal MW, van Zyl-Smit R: Hepatitis C virus infection in chronic haemodialysis patients–relationship to blood transfusions and dialyser re-use. S Afr Med J. 2000, 90 (6): 621-625.PubMed
4.
go back to reference Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K: Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney Int. 1993, 43 (6): 1353-1356. 10.1038/ki.1993.190.CrossRefPubMed Knudsen F, Wantzin P, Rasmussen K, Ladefoged SD, Lokkegaard N, Rasmussen LS, Lassen A, Krogsgaard K: Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease. Kidney Int. 1993, 43 (6): 1353-1356. 10.1038/ki.1993.190.CrossRefPubMed
5.
go back to reference Allander T, Medin C, Jacobson SH, Grillner L, Persson MA: Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol. 1994, 43 (4): 415-419. 10.1002/jmv.1890430417.CrossRefPubMed Allander T, Medin C, Jacobson SH, Grillner L, Persson MA: Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol. 1994, 43 (4): 415-419. 10.1002/jmv.1890430417.CrossRefPubMed
6.
go back to reference Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A: Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission. J Clin Microbiol. 1998, 36 (10): 3040-3043.PubMedPubMedCentral Le Pogam S, Le Chapois D, Christen R, Dubois F, Barin F, Goudeau A: Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission. J Clin Microbiol. 1998, 36 (10): 3040-3043.PubMedPubMedCentral
7.
go back to reference Ozer A, Yakupogullari Y, Beytur A, Beytur L, Koroglu M, Salman F, Aydogan F: Risk factors of hepatitis B virus infection in turkey: a population-based, case–control study: risk factors for HBV infection. Hepat Mon. 2011, 11 (4): 263-268.PubMedPubMedCentral Ozer A, Yakupogullari Y, Beytur A, Beytur L, Koroglu M, Salman F, Aydogan F: Risk factors of hepatitis B virus infection in turkey: a population-based, case–control study: risk factors for HBV infection. Hepat Mon. 2011, 11 (4): 263-268.PubMedPubMedCentral
8.
go back to reference Fabrizi F, Marzano A, Messa P, Martin P, Lampertico P: Hepatitis B virus infection in the dialysis population: current perspectives. Int J Artif Organs. 2008, 31 (5): 386-394.PubMed Fabrizi F, Marzano A, Messa P, Martin P, Lampertico P: Hepatitis B virus infection in the dialysis population: current perspectives. Int J Artif Organs. 2008, 31 (5): 386-394.PubMed
9.
go back to reference Taal MW, van Zyl-Smit R: Cost-effectiveness of hepatitis B vaccination in haemodialysis patients. S Afr Med J. 2001, 91 (4): 340-344.PubMed Taal MW, van Zyl-Smit R: Cost-effectiveness of hepatitis B vaccination in haemodialysis patients. S Afr Med J. 2001, 91 (4): 340-344.PubMed
10.
go back to reference Mohamed WZ: Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center. Saudi J Kidney Dis Transpl. 2010, 21 (3): 548-554.PubMed Mohamed WZ: Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center. Saudi J Kidney Dis Transpl. 2010, 21 (3): 548-554.PubMed
11.
go back to reference Patel PR, Thompson ND, Kallen AJ, Arduino MJ: Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis. 2010, 56 (2): 371-378. 10.1053/j.ajkd.2010.01.025.CrossRefPubMed Patel PR, Thompson ND, Kallen AJ, Arduino MJ: Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients. Am J Kidney Dis. 2010, 56 (2): 371-378. 10.1053/j.ajkd.2010.01.025.CrossRefPubMed
12.
go back to reference Saune K, Kamar N, Miedouge M, Weclawiak H, Dubois M, Izopet J, Rostaing L: Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey. Nephrol Dial Transplant. 2010, 26 (7): 2309-2316.CrossRefPubMed Saune K, Kamar N, Miedouge M, Weclawiak H, Dubois M, Izopet J, Rostaing L: Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey. Nephrol Dial Transplant. 2010, 26 (7): 2309-2316.CrossRefPubMed
13.
go back to reference Alashek WA, McIntyre CW, Taal MW: Provision and quality of dialysis services in Libya. Hemodial Int. 2011, 15 (4): 444-452. 10.1111/j.1542-4758.2011.00588.x.CrossRefPubMed Alashek WA, McIntyre CW, Taal MW: Provision and quality of dialysis services in Libya. Hemodial Int. 2011, 15 (4): 444-452. 10.1111/j.1542-4758.2011.00588.x.CrossRefPubMed
14.
go back to reference Elzouki A, Esmeo M, Samod M, Abonaja A, Alagi B, Daw M: Prevalence of hepatitis B, C and HIV infection in Libya: a population-based nationwide seropepidemiological study. Liver Int. 2006, 26: 20- Elzouki A, Esmeo M, Samod M, Abonaja A, Alagi B, Daw M: Prevalence of hepatitis B, C and HIV infection in Libya: a population-based nationwide seropepidemiological study. Liver Int. 2006, 26: 20-
15.
go back to reference Elzouki AN: Hepatitis B infection in Libya:The magnitude of the problem. The Libyan Journal of Infectious Diseases. 2008, 2 (1): 20-25. Elzouki AN: Hepatitis B infection in Libya:The magnitude of the problem. The Libyan Journal of Infectious Diseases. 2008, 2 (1): 20-25.
16.
go back to reference Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM: Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J. 2002, 23 (11): 1356-1360.PubMed Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM: Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J. 2002, 23 (11): 1356-1360.PubMed
17.
go back to reference Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, et al: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000, 355 (9207): 887-891. 10.1016/S0140-6736(99)06527-7.CrossRefPubMed Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, et al: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet. 2000, 355 (9207): 887-891. 10.1016/S0140-6736(99)06527-7.CrossRefPubMed
19.
go back to reference Te HS, Jensen DM: Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010, 14 (1): 1-21. 10.1016/j.cld.2009.11.009. viiCrossRefPubMed Te HS, Jensen DM: Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010, 14 (1): 1-21. 10.1016/j.cld.2009.11.009. viiCrossRefPubMed
20.
go back to reference WHO: Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat. 1999, 6 (1): 35-47.CrossRef WHO: Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat. 1999, 6 (1): 35-47.CrossRef
21.
go back to reference Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE: Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut. 2002, 51 (3): 429-433. 10.1136/gut.51.3.429.CrossRefPubMedPubMedCentral Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE: Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut. 2002, 51 (3): 429-433. 10.1136/gut.51.3.429.CrossRefPubMedPubMedCentral
22.
go back to reference Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N: Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-rochd university hospital, casablanca. Nephrol Ther. 2005, 1 (5): 274-284. 10.1016/j.nephro.2005.06.012.CrossRefPubMed Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N: Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-rochd university hospital, casablanca. Nephrol Ther. 2005, 1 (5): 274-284. 10.1016/j.nephro.2005.06.012.CrossRefPubMed
23.
go back to reference Souqiyyeh MZ, Al-Attar MB, Zakaria H, Shaheen FA: Dialysis centers in the kingdom of saudi arabia. Saudi J Kidney Dis Transpl. 2001, 12 (3): 293-304.PubMed Souqiyyeh MZ, Al-Attar MB, Zakaria H, Shaheen FA: Dialysis centers in the kingdom of saudi arabia. Saudi J Kidney Dis Transpl. 2001, 12 (3): 293-304.PubMed
24.
go back to reference Jemni S, Ikbel K, Kortas M, Mahjoub J, Ghachem L, Bidet JM, Boukef K: Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouv Rev Fr Hematol. 1994, 36 (5): 349-351.PubMed Jemni S, Ikbel K, Kortas M, Mahjoub J, Ghachem L, Bidet JM, Boukef K: Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouv Rev Fr Hematol. 1994, 36 (5): 349-351.PubMed
25.
go back to reference Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H: Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006, 28 (8): 729-735. 10.1080/08860220600925602.CrossRefPubMed Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H: Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006, 28 (8): 729-735. 10.1080/08860220600925602.CrossRefPubMed
26.
go back to reference Batieha A, Abdallah S, Maghaireh M, Awad Z, Al-Akash N, Batieneh A, Ajlouni KA: Epidemiology and cost of haemodialysis in Jordan. East Mediterr Health J. 2007, 13 (3): 654-663.PubMed Batieha A, Abdallah S, Maghaireh M, Awad Z, Al-Akash N, Batieneh A, Ajlouni KA: Epidemiology and cost of haemodialysis in Jordan. East Mediterr Health J. 2007, 13 (3): 654-663.PubMed
27.
go back to reference Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW: Mortality among hemodialysis patients in europe, japan, and the united states: case-mix effects. Am J Kidney Dis. 2004, 44 (5 Suppl 2): 16-21.CrossRefPubMed Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW: Mortality among hemodialysis patients in europe, japan, and the united states: case-mix effects. Am J Kidney Dis. 2004, 44 (5 Suppl 2): 16-21.CrossRefPubMed
28.
go back to reference Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW: Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003, 63 (6): 2222-2229. 10.1046/j.1523-1755.2003.00017.x.CrossRefPubMed Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW: Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003, 63 (6): 2222-2229. 10.1046/j.1523-1755.2003.00017.x.CrossRefPubMed
29.
go back to reference Ferreira RC, Teles SA, Dias MA, Tavares VR, Silva SA, Gomes SA, Yoshida CF, Martins RM: Hepatitis B virus infection profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes. Mem Inst Oswaldo Cruz. 2006, 101 (6): 689-692. 10.1590/S0074-02762006000600019.CrossRefPubMed Ferreira RC, Teles SA, Dias MA, Tavares VR, Silva SA, Gomes SA, Yoshida CF, Martins RM: Hepatitis B virus infection profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes. Mem Inst Oswaldo Cruz. 2006, 101 (6): 689-692. 10.1590/S0074-02762006000600019.CrossRefPubMed
30.
go back to reference Chandra M, Khaja MN, Hussain MM, Poduri CD, Farees N, Habeeb MA, Krishnan S, Ramareddy GV, Habibullah CM: Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology. 2004, 47 (6): 374-376. 10.1159/000080883.CrossRefPubMed Chandra M, Khaja MN, Hussain MM, Poduri CD, Farees N, Habeeb MA, Krishnan S, Ramareddy GV, Habibullah CM: Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology. 2004, 47 (6): 374-376. 10.1159/000080883.CrossRefPubMed
31.
go back to reference Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY: Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004, 32 (8): 493-495. 10.1016/j.ajic.2003.12.009.CrossRefPubMed Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY: Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004, 32 (8): 493-495. 10.1016/j.ajic.2003.12.009.CrossRefPubMed
34.
go back to reference Al Hijazat M, Ajlouni YM: Hepatitis B infection among patients receiving chronic hemodialysis at the royal medical services in jordan. Saudi J Kidney Dis Transpl. 2008, 19 (2): 260-267.PubMed Al Hijazat M, Ajlouni YM: Hepatitis B infection among patients receiving chronic hemodialysis at the royal medical services in jordan. Saudi J Kidney Dis Transpl. 2008, 19 (2): 260-267.PubMed
35.
go back to reference Alashek WA, McIntyre CW, Taal MW: Determinants of survival in patients receiving dialysis in Libya. Hemodial Int. 2012, 10.1111/j.1542-4758.2012.00728.x. [Epub ahead of print] Alashek WA, McIntyre CW, Taal MW: Determinants of survival in patients receiving dialysis in Libya. Hemodial Int. 2012, 10.1111/j.1542-4758.2012.00728.x. [Epub ahead of print]
36.
go back to reference Saxena AK, Panhotra BR: The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J Am Geriatr Soc. 2004, 52 (2): 242-246. 10.1111/j.1532-5415.2004.52062.x.CrossRefPubMed Saxena AK, Panhotra BR: The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J Am Geriatr Soc. 2004, 52 (2): 242-246. 10.1111/j.1532-5415.2004.52062.x.CrossRefPubMed
37.
go back to reference Mostaghni AA, Soltanian A, Mokhtari E, Japoni S, Mehrabani D: Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran: HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011, 11 (3): 200-202.PubMedPubMedCentral Mostaghni AA, Soltanian A, Mokhtari E, Japoni S, Mehrabani D: Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran: HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011, 11 (3): 200-202.PubMedPubMedCentral
38.
go back to reference Hardy NM, Sandroni S, Danielson S, Wilson WJ: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol. 1992, 38 (1): 44-48.PubMed Hardy NM, Sandroni S, Danielson S, Wilson WJ: Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol. 1992, 38 (1): 44-48.PubMed
39.
go back to reference Jasuja S, Gupta AK, Choudhry R, Kher V, Aggarwal DK, Mishra A, Agarwal M, Sarin A, Mishra MK, Raina V: Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol. 2009, 19 (2): 62-67. 10.4103/0971-4065.53324.CrossRefPubMedPubMedCentral Jasuja S, Gupta AK, Choudhry R, Kher V, Aggarwal DK, Mishra A, Agarwal M, Sarin A, Mishra MK, Raina V: Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol. 2009, 19 (2): 62-67. 10.4103/0971-4065.53324.CrossRefPubMedPubMedCentral
40.
go back to reference Vladutiu DS, Cosa A, Neamtu A, State D, Braila M, Gherman M, Patiu IM, Dulau-Florea I: Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map?. J Viral Hepat. 2000, 7 (4): 313-319. 10.1046/j.1365-2893.2000.00222.x.CrossRefPubMed Vladutiu DS, Cosa A, Neamtu A, State D, Braila M, Gherman M, Patiu IM, Dulau-Florea I: Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map?. J Viral Hepat. 2000, 7 (4): 313-319. 10.1046/j.1365-2893.2000.00222.x.CrossRefPubMed
41.
go back to reference Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004, 65 (6): 2335-2342. 10.1111/j.1523-1755.2004.00649.x.CrossRefPubMed Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, Rayner HC, Greenwood RN, Akiba T, Young EW: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004, 65 (6): 2335-2342. 10.1111/j.1523-1755.2004.00649.x.CrossRefPubMed
42.
go back to reference Hitzler WE, Runkel S: Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV. Transfusion. 2001, 41 (3): 333-337. 10.1046/j.1537-2995.2001.41030333.x.CrossRefPubMed Hitzler WE, Runkel S: Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV. Transfusion. 2001, 41 (3): 333-337. 10.1046/j.1537-2995.2001.41030333.x.CrossRefPubMed
43.
go back to reference Doghman NA MYA, Najem FI, SA E-S: Blood donor screening for hepatitis B and C in Benghazi: additional tests are needed. Libyan J Infect Dis. 2007, 1 (1): 100-102. Doghman NA MYA, Najem FI, SA E-S: Blood donor screening for hepatitis B and C in Benghazi: additional tests are needed. Libyan J Infect Dis. 2007, 1 (1): 100-102.
44.
go back to reference Pereira BJ: Hepatitis C infection and post-transplantation liver disease. Nephrol Dial Transplant. 1995, 10 (Suppl 1): 58-67.CrossRefPubMed Pereira BJ: Hepatitis C infection and post-transplantation liver disease. Nephrol Dial Transplant. 1995, 10 (Suppl 1): 58-67.CrossRefPubMed
45.
go back to reference Dusheiko G, Song E, Bowyer S, Whitcutt M, Maier G, Meyers A, Kew MC: Natural history of hepatitis B virus infection in renal transplant recipients–a fifteen-year follow-up. Hepatology. 1983, 3 (3): 330-336.CrossRefPubMed Dusheiko G, Song E, Bowyer S, Whitcutt M, Maier G, Meyers A, Kew MC: Natural history of hepatitis B virus infection in renal transplant recipients–a fifteen-year follow-up. Hepatology. 1983, 3 (3): 330-336.CrossRefPubMed
46.
go back to reference Izopet J, Sandres-Saune K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L: Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005, 77 (1): 70-76. 10.1002/jmv.20415.CrossRefPubMed Izopet J, Sandres-Saune K, Kamar N, Salama G, Dubois M, Pasquier C, Rostaing L: Incidence of HCV infection in French hemodialysis units: a prospective study. J Med Virol. 2005, 77 (1): 70-76. 10.1002/jmv.20415.CrossRefPubMed
47.
go back to reference Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S: Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008, 12 (3): 378-382. 10.1111/j.1542-4758.2008.00284.x.CrossRefPubMed Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S: Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008, 12 (3): 378-382. 10.1111/j.1542-4758.2008.00284.x.CrossRefPubMed
48.
go back to reference Karkar A, Abdelrahman M, Ghacha R, Malik TQ: Prevention of viral transmission in HD units: the value of isolation. Saudi J Kidney Dis Transpl. 2006, 17 (2): 183-188.PubMed Karkar A, Abdelrahman M, Ghacha R, Malik TQ: Prevention of viral transmission in HD units: the value of isolation. Saudi J Kidney Dis Transpl. 2006, 17 (2): 183-188.PubMed
49.
go back to reference Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, Deaf A, Hamdy L, Tony EA: Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012, 12 (4): 253-258.CrossRefPubMedPubMedCentral Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, Deaf A, Hamdy L, Tony EA: Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012, 12 (4): 253-258.CrossRefPubMedPubMedCentral
Metadata
Title
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors
Authors
Wiam A Alashek
Christopher W McIntyre
Maarten W Taal
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-265

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue